title: Specific Antinuclear Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis Are Associated with Improvement of Skin Thickening.
authors.affiliation: Adjunct Head of Clinics, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital; carolien.bonroy@uzgent.be.
authors.forename: Carolien
authors.initials: C
authors.lastname: Bonroy
authors.affiliation: Department of Rheumatology, Ghent University Hospital;
authors.forename: Vanessa
authors.initials: V
authors.lastname: Smith
authors.affiliation: Biostatistics Unit, Department of Public Health, Ghent University;
authors.forename: Ellen
authors.initials: E
authors.lastname: Deschepper
authors.affiliation: Department of Rheumatology, Ghent University Hospital;
authors.forename: Filip
authors.initials: F
authors.lastname: De Keyser
authors.affiliation: Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, Belgium.
authors.forename: Katrien
authors.initials: K
authors.lastname: Devreese
mesh_terms: D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood / Q000187:drug effects*; D001402:B-Lymphocytes / Q000187:drug effects; D016001:Confidence Intervals; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008212:Lymphocyte Depletion / Q000379:methods*; D008297:Male; D000069283:Rituximab / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000276:immunology*; D012867:Skin / Q000187:drug effects / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D000069283:Rituximab